GH Research PLC (GHRS)
11.36
-0.36
(-3.07%)
USD |
NASDAQ |
Apr 23, 16:00
11.36
0.00 (0.00%)
After-Hours: 20:00
GH Research Cash from Investing (TTM): -54.10M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -54.10M |
September 30, 2023 | -138.72M |
June 30, 2023 | -138.72M |
March 31, 2023 | -138.70M |
December 31, 2022 | -84.69M |
September 30, 2022 | -0.068M |
June 30, 2022 | -0.103M |
Date | Value |
---|---|
March 31, 2022 | -0.093M |
December 31, 2021 | -0.104M |
September 30, 2021 | -0.085M |
June 30, 2021 | -0.035M |
March 31, 2021 | -0.021M |
December 31, 2020 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-138.72M
Minimum
Jun 2023
--
Maximum
Dec 2020
-42.73M
Average
-0.103M
Median
Jun 2022
Cash from Investing (TTM) Benchmarks
Amarin Corp PLC | -25.52M |
Jazz Pharmaceuticals PLC | -163.06M |
Prothena Corp PLC | -2.773M |
Iterum Therapeutics PLC | 23.34M |
Mural Oncology PLC | -- |